Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

Key value for chemical safety assessment

Additional information

Absorption and distribution

After oral application of phenazone (300 mg and 600 mg) plasma levels of 11 ug/mL and 21 ug/mL after 1 h to 3 h, respectively, and half life times ranging from 10 h to 13 h could be observed.

Metabolism

The predominant biotransformation step of phenazone is hydroxylation with two main metabolites 4-hydroxy-phenazone and 3 -hydroxymethyl-phenazone and subsequent glucuronidation. Conjugates (glucoronides and sulphates) of the hydroxylated intermediates will be excreted with the urine.

Excretion

Excretion of phenazone after oral application is predominantly with the urine (more than 99 % in 5 days).